Effect of preoperative hyperfibrinogenemia on recurrence of colorectal cancer without a systemic inflammatory response

World Journal of Surgery

Volumn 33, Issue 6, 2009, Pages 1298-1305

  Yamashita, Hiroharu ^a   Kitayama, Joji ^a   Taguri, Masataka ^a   Nagawa, Hirokazu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANAMNESIS; ARTICLE; BIOCHEMISTRY; BLOOD CELL COUNT; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; ENDOSCOPY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; HYPERFIBRINOGENEMIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; PREOPERATIVE COMPLICATION; RETROSPECTIVE STUDY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 67349214950     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-9992-7     Document Type: Article

References (35)

1. J Sakamoto Y Ohashi C Hamada 2004 Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials J Clin Oncol 22 484 492 (Pubitemid 41079778)
2. JA Laurie CG Moertel TR Fleming 1989 Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil: the North Central Cancer Treatment Group and the Mayo Clinic J Clin Oncol 7 1447 1456
3. T Akasu Y Moriya Y Ohashi 2006 Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial Jpn J Clin Oncol 36 237 244
4. CG Moertel TR Fleming JS Macdonald 1995 Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report Ann Intern Med 122 321 326
5. DZ Chu CA Erickson MP Russell 1991 Prognostic significance of carcinoembryonic antigen in colorectal carcinoma: serum levels before and after resection and before recurrence Arch Surg 126 314 316
6. N Wolmark B Fisher HS Wieand 1984 The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer: results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials Ann Surg 199 375 382
7. WS Wang JK Lin TJ Chiou 2000 Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience Jpn J Clin Oncol 30 12 16
8. J Louhimo M Carpelan-Holmstrom H Alfthan 2002 Serum HCG beta, CA 72-4 and CEA are independent prognostic factors in colorectal cancer Int J Cancer 101 545 548
9. LE Harrison JG Guillem P Paty 1997 Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients J Am Coll Surg 185 55 59 (Pubitemid 27276742)
10. HJ Wanebo B Rao CM Pinsky 1978 Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer N Engl J Med 299 448 451 (Pubitemid 9011330)
11. T Takahashi T Kato S Kodaira 1996 Prognostic factors of colorectal cancer: results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy Am J Clin Oncol 19 408 415 (Pubitemid 26242243)
12. H Yamashita J Kitayama H Nagawa 2005 Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer Jpn J Clin Oncol 35 595 600 (Pubitemid 41662696)
13. H Yamashita J Kitayama N Kanno 2006 Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer BMC Cancer 6 147 (Pubitemid 44057311)
14. Z Chen PS Malhotra GR Thomas 1999 Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer Clin Cancer Res 5 1369 1379 (Pubitemid 29282941)
15. JS Palumbo KW Kombrinck AF Drew 2000 Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells Blood 96 3302 3309
16. JS Palumbo JM Potter LS Kaplan 2002 Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice Cancer Res 62 6966 6972 (Pubitemid 35424088)
17. V Costantini LR Zacharski TE Moritz 1990 The platelet count in carcinoma of the lung and colon Thromb Haemost 64 501 505
18. M Oya Y Akiyama T Okuyama 2001 High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer Jpn J Clin Oncol 31 388 394 (Pubitemid 32958591)
19. V Abbasciano MP Bianchi L Trevisani 1995 Platelet activation and fibrinolysis in large bowel cancer Oncology 52 381 384
20. LH Iversen O Thorlacius-Ussing 2002 Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer Thromb Haemost 87 402 408 (Pubitemid 34232479)
21. K Blackwell H Hurwitz G Lieberman 2004 Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma Cancer 101 77 82 (Pubitemid 38812425)
22. Q Wang R Xie QY Zhang 2005 Clinical significance of plasma fibrinogen level in patients with colorectal cancer Zhonghua Zhong Liu Za Zhi 27 544 546
23. T Nozoe T Matsumata M Kitamura 1998 Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer Am J Surg 176 335 338 (Pubitemid 28514444)
24. H Shimada H Kitabayashi Y Nabeya 2003 Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 24 31 (Pubitemid 36183122)
25. H Nakanishi N Araki I Kudawara 2002 Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma Int J Cancer 99 167 170 (Pubitemid 34309471)
26. AP Stamatiadis M St. Toumanidou GP Vyssoulis 1990 Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer: a multivariate analysis Cancer 65 2055 2057 (Pubitemid 20147647)
27. YC Chung YF Chang 2003 Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator Eur J Gastroenterol Hepatol 15 369 373 (Pubitemid 36521034)
28. DC McMillan K Canna CS McArdle 2003 Systemic inflammatory response predicts survival following curative resection of colorectal cancer Br J Surg 90 215 219 (Pubitemid 36237897)
29. S Black I Kushner D Samols 2004 C-reactive protein J Biol Chem 279 48487 48490 (Pubitemid 39625721)
30. JN Poynter SB Gruber PD Higgins 2005 Statins and the risk of colorectal cancer N Engl J Med 352 2184 2192 (Pubitemid 40727085)
31. R Kleemann PP Gervois L Verschuren 2003 Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation Blood 101 545 551 (Pubitemid 36077576)
32. JS Palumbo KE Talmage JV Massari 2005 Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 178 185 (Pubitemid 40053080)
33. H Yano J Kitayama K Hatano 2001 Clustered cancer cells show a distinct adhesion behavior from single cell form under physiological shear conditions J Exp Clin Cancer Res 20 407 412 (Pubitemid 32980043)
34. B Nieswandt M Hafner B Echtenacher 1999 Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 1295 1300 (Pubitemid 29136261)
35. AJ Gale SG Gordon 2001 Update on tumor cell procoagulant factors Acta Haematol 106 25 32 (Pubitemid 32830513)